|
23.08.2017 21:18:00
|
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PetMed Express, Inc. (PETS)
NEW YORK, Aug. 23, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/pets.
The investigation concerns whether PetMed and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On August 23, 2017, Aurelius Value published an article alleging that PetMed targets opioid users with Google ads and other marketing techniques aimed at facilitating the abuse of opioids. Following this news, PetMed stock dropped as much as $6.26 per share, or 15.88%, during intraday trading on August 23, 2017.
If you are aware of any facts relating to this investigation, or purchased shares of PetMed, you can assist this investigation by visiting the firm's site: www.bgandg.com/pets. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-petmed-express-inc-pets-300508680.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PetMed Express Inc.mehr Nachrichten
|
16.12.24 |
NASDAQ Composite Index-Papier PetMed Express-Aktie: So viel Verlust hätte ein Investment in PetMed Express von vor 5 Jahren bedeutet (finanzen.at) | |
|
11.12.24 |
Börse New York in Grün: NASDAQ Composite liegt zum Ende des Mittwochshandels im Plus (finanzen.at) | |
|
11.12.24 |
Börse New York in Grün: NASDAQ Composite klettert am Nachmittag (finanzen.at) | |
|
11.12.24 |
Freundlicher Handel: NASDAQ Composite legt am Mittag zu (finanzen.at) | |
|
10.12.24 |
Starker Wochentag in New York: Anleger lassen NASDAQ Composite zum Start steigen (finanzen.at) | |
|
09.12.24 |
Börse New York in Rot: NASDAQ Composite liegt zum Handelsende im Minus (finanzen.at) | |
|
09.12.24 |
Handel in New York: So entwickelt sich der NASDAQ Composite am Montagnachmittag (finanzen.at) | |
|
09.12.24 |
Anleger in New York halten sich zurück: NASDAQ Composite schwächelt (finanzen.at) |
Analysen zu PetMed Express Inc.mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.